Actively Recruiting
Phase II Trial of Immunonutrition in Hepatectomy
Led by Tata Memorial Centre · Updated on 2026-02-09
100
Participants Needed
1
Research Sites
121 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A randomised open labelled study to evalaute the impact of immunonutrition in Patients Undergoing Hepatectomies for Liver Tumors
CONDITIONS
Official Title
Phase II Trial of Immunonutrition in Hepatectomy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with liver tumors planned for major hepatectomies (defined as resection of �3e/= 3 liver segments)
- Age above 18 years
- ASA class I-III
You will not qualify if you...
- Preoperative severe renal failure (estimated glomerular filtration rate < 30 ml/min)
- History of hypersensitivity to arginine, omega-3 fatty acids, or nucleotide
- Inability to take oral nutrition
- Pregnancy
- Mental condition rendering the subject unable to understand the nature, endpoints and consequences of the trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Dr. Shraddha Patkar
Mumbai, Maharashtra, India, 400012
Actively Recruiting
Research Team
D
Dr. Shraddha Patkar, MD MCh
CONTACT
D
Dr Mahesh Goel, MBBS, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here